Results 281 to 290 of about 46,900 (298)

Dipeptidyl peptidase 4 – An important digestive peptidase in Tenebrio molitor larvae

Insect Biochemistry and Molecular Biology, 2016
Marina V Serebryakova, Mikhail A Belozersky, Brenda Oppert   +2 more
exaly  

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham, Christos Argyropoulos, Nhan Dinh   +2 more
openaire   +1 more source

Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition

Hypertension, 2014
Jessica K Devin, Mias Pretorius, Hui Nian   +2 more
exaly  

Dipeptidyl peptidase‐4 inhibitors and cardiovascular safety

Medical Journal of Australia, 2014
openaire   +2 more sources

Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease

Diabetes and Vascular Disease Research, 2012
Aili Sun, Guang-Ju Guan, Jing Cheng
exaly  

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism

Hypertension, 2012
Limei Liu, Wing Tak Wong, Xiao Yu Tian
exaly  

Circulating Dipeptidyl Peptidase IV Activity Correlates With Cardiac Dysfunction in Human and Experimental Heart Failure

Circulation: Heart Failure, 2013
Leonardo Dos Santos, Luciene Cristina Gastalho Campos, Alfredo J Mansur   +2 more
exaly  

Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and α-glucosidase inhibitory activity

Journal of Functional Foods, 2016
Zhu Zeng, Junyi Luo, Fanglei Zuo
exaly  

Regulation of Expression and Function of Dipeptidyl Peptidase 4 (DP4), DP8/9, and DP10 in Allergic Responses of the Lung in Rats

Journal of Histochemistry and Cytochemistry, 2008
Michael Stephan, Andreas Schmiedl, Leona Wagner   +2 more
exaly  

Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes

Expert Opinion on Drug Safety, 2015
André J Scheen
exaly